Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3965 | Text material for psychoeducation and audio for relaxation techniques Wiki | 1.00 |
| drug2421 | Molnupiravir Wiki | 0.71 |
| drug2916 | Placebo Wiki | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
COVID-19 pandemic has drastically affected the life of millions of people, with significant socio-economic and psychological impact. Healthcare workers, in particular, are working with high levels of stress and emotional exhaustion, with risk of long term consequences such as stress and anxiety disorders. Previous studies have demonstrated the effectiveness of virtual reality (VR) in preventing and treating stress and anxiety disorders. Therefore,in this study we aim at investigating the advantages of using a virtual reality-based protocol for reducing stress and anxiety in healthcare workers involved in the COVID-19 pandemic.
Description: A 20 item measure of the level of the state anxiety
Measure: Change in score at the State-Trait Anxiety Inventory -Y2 Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upDescription: A 10 item measure of the level of stress perceived in the last month
Measure: Change in score at the Perceived Stress Scale Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upDescription: A 21 item in 3 self-report scales which measures depression, anxiety and stress
Measure: Change in score at the Depression, Anxiety ans Stress Scale-21 items Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upDescription: A 7 item measure at the ad hoc questionnaire to assess the knowledge of stress and anxiety
Measure: Change in score of knowledge on stress and anxiety Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upDescription: A measure which defines the state of health and the perceived quality of life
Measure: Change in score at the EQ-5D-5L Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upDescription: A 22 item measure of the subjective stress perception and the factors "intrusion" and "avoidance"
Measure: Change in score at the Impact of Event Scale - Revised Time: Baseline; immediately after the procedure/intervention; 3 months and 6 months follow-upAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports